232 related articles for article (PubMed ID: 25401051)
1. Strategies to Detect Hepatic Myofibroblasts in Liver Cirrhosis of Different Etiologies.
Iwaisako K; Taura K; Koyama Y; Takemoto K; Asagiri M
Curr Pathobiol Rep; 2014; 2(4):209-215. PubMed ID: 25401051
[TBL] [Abstract][Full Text] [Related]
2. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
3. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
Iwaisako K; Brenner DA; Kisseleva T
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
[TBL] [Abstract][Full Text] [Related]
4. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.
Xu J; Liu X; Koyama Y; Wang P; Lan T; Kim IG; Kim IH; Ma HY; Kisseleva T
Front Pharmacol; 2014; 5():167. PubMed ID: 25100997
[TBL] [Abstract][Full Text] [Related]
5. The Origin and Fate of Liver Myofibroblasts.
Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T
Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.
Fausther M; Lavoie EG; Dranoff JA
Curr Pathobiol Rep; 2013 Sep; 1(3):225-230. PubMed ID: 23997993
[TBL] [Abstract][Full Text] [Related]
7. Origin of myofibroblasts in the fibrotic liver in mice.
Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909
[TBL] [Abstract][Full Text] [Related]
8. New therapies for hepatic fibrosis.
Koyama Y; Brenner DA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S75-9. PubMed ID: 26206573
[TBL] [Abstract][Full Text] [Related]
9. Origin of myofibroblasts in liver fibrosis.
Brenner DA; Kisseleva T; Scholten D; Paik YH; Iwaisako K; Inokuchi S; Schnabl B; Seki E; De Minicis S; Oesterreicher C; Taura K
Fibrogenesis Tissue Repair; 2012; 5(Suppl 1):S17. PubMed ID: 23259769
[TBL] [Abstract][Full Text] [Related]
10. Origin and role of hepatic myofibroblasts in hepatocellular carcinoma.
Yavuz BG; Pestana RC; Abugabal YI; Krishnan S; Chen J; Hassan MM; Wolff RA; Rashid A; Amin HM; Kaseb AO
Oncotarget; 2020 Mar; 11(13):1186-1201. PubMed ID: 32284794
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
12. Liver repair and regeneration after ischemia-reperfusion injury is associated with prolonged fibrosis.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G323-G331. PubMed ID: 30543462
[TBL] [Abstract][Full Text] [Related]
13. Origin and function of myofibroblasts in the liver.
Wells RG; Schwabe RF
Semin Liver Dis; 2015 May; 35(2):97-106. PubMed ID: 25974896
[TBL] [Abstract][Full Text] [Related]
14. Cytoglobin is expressed in hepatic stellate cells, but not in myofibroblasts, in normal and fibrotic human liver.
Motoyama H; Komiya T; Thuy le TT; Tamori A; Enomoto M; Morikawa H; Iwai S; Uchida-Kobayashi S; Fujii H; Hagihara A; Kawamura E; Murakami Y; Yoshizato K; Kawada N
Lab Invest; 2014 Feb; 94(2):192-207. PubMed ID: 24296877
[TBL] [Abstract][Full Text] [Related]
15. Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts.
Kawada N
Front Physiol; 2015; 6():329. PubMed ID: 26617531
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
Mallat A; Lotersztajn S
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
[TBL] [Abstract][Full Text] [Related]
17. The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts.
Liang S; Kisseleva T; Brenner DA
Front Physiol; 2016; 7():17. PubMed ID: 26869935
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
Elpek GÖ
World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
[TBL] [Abstract][Full Text] [Related]
20. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
